Andale, Roger A.

HRN: 18-67-33  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/14/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/14/2024
04/20/2024
IV
4.5 Grams
Q8hrs
Soft Tissue Infection With Hyperglycemic Crisis
Waiting Final Action 
04/15/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/15/2024
04/21/2024
IVT
600mg
Q8
Communicating Abscess Left Buttocks
Waiting Final Action 
04/22/2024
CLINDAMYCIN 300MG (CAP)
04/22/2024
04/29/2024
ORAL
300mg/cap
TID
Left Buttocks Abscess
Waiting Final Action 
04/23/2024
CLINDAMYCIN 300MG (CAP)
04/23/2024
04/27/2024
PO
300mg
Q6
Soft Tissue Abscess
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: